Copyright
©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Sep 7, 2012; 18(33): 4604-4609
Published online Sep 7, 2012. doi: 10.3748/wjg.v18.i33.4604
Published online Sep 7, 2012. doi: 10.3748/wjg.v18.i33.4604
What MELD score mandates use of entecavir for ACLF-HBV HBeAg-negative patients?
Ying Yan, Li Mai, Yu-Bao Zheng, Shao-Quan Zhang, Wen-Xiong Xu, Zhi-Liang Gao, Wei-Min Ke, Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, Guangdong Province, China
Author contributions: Yan Y and Mai L contributed equally to this work; Yan Y, Mai L and Ke WM designed the research; Yan Y, Mai L, Zheng YB, Zhang SQ, Xu WX and Gao ZL performed the research; Yan Y, Mai L, Zheng YB, Zhang SQ and Xu WX collected data; Yan Y and Mai L analyzed the data; Yan Y, Mai L and Ke WM wrote the paper.
Supported by Grants from the Technology Project Fund of Guangdong Province, China, No. 2010B080701024; The Natural Science Fund of Guangdong Province, No. 10451008901004818; The National Natural Science Foundation of China, No. 30971356; The National Grand Program on Key Infectious Disease in the Treatment and Prevention of Infectious Diseases of AIDS and Viral Hepatitis, China, No. 2012ZX10002007-002; The Medical science and Technology Research Fund of Guangdong Province, China, No. B2011101
Correspondence to: Wei-Min Ke, Professor, Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, Guangdong Province, China. kwm1999@163.com
Telephone: +86-20-85253172 Fax: +86-20-85253172
Received: October 13, 2011
Revised: April 13, 2012
Accepted: April 20, 2012
Published online: September 7, 2012
Revised: April 13, 2012
Accepted: April 20, 2012
Published online: September 7, 2012
Core Tip